tiprankstipranks
Trending News
More News >
Ultragenyx Pharmaceutical (RARE)
NASDAQ:RARE
Advertisement

Ultragenyx Pharmaceutical (RARE) Revenue

Compare
896 Followers

Ultragenyx Pharmaceutical Revenue

Ultragenyx Pharmaceutical had a revenue of 139.29M in the quarter ending Mar 31, 2025, with -15.52%. This bring the company's revenue in the last twelve months to 590.69M, Decreased 5.44%. In the fiscal year ending Dec 31, 2024, Ultragenyx Pharmaceutical had annual revenue of 560.23M with 29.01% growth.
Revenue (ttm)
590.69M
Revenue Growth
33.46%
P/S Ratio
4.44
Revenue/Employee
$432,944
Employees
1,294
Market Cap
$2.49B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
560.23M125.98M+29.01%
Dec 31, 2023
434.25M70.92M+19.52%
Dec 31, 2022
363.33M11.92M+3.39%
Dec 31, 2021
351.41M80.38M+29.66%
Dec 31, 2020
271.03M167.32M+161.32%
Dec 31, 2019
103.71M52.22M+101.41%
Dec 31, 2018
51.49M48.88M+1,871.48%
Dec 31, 2017
2.61M2.48M+1,863.91%
Dec 31, 2016
133.00K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis